$GILD Recent Headlines Winning approval for new drugs may

New Post Public Reply Private Reply Replies (0) Message Board

Mar 6, 2014 at 10:58 AM

$GILD Recent Headlines

Winning approval for new drugs may get harder, analyst warns 3:56 p.m. Feb. 28, 2014 - blogs.marketwatch.com
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
When it comes to stocks, play follow the leader 3:54 p.m. Feb. 13, 2014 - The Trading Deck
3D Systems down on weak outlook, CVS quits cigarettes 4:16 p.m. Feb. 5, 2014 - Saumya Vaishampayan
Time Warner, Twitter, Walt Disney are stocks to watch 5:48 a.m. Feb. 5, 2014 - Sue Chang
Tableau Software, Myriad shares rally after earnings 6:02 p.m. Feb. 4, 2014 - Wallace Witkowski
Gilead does the expected by beating earnings and sales forecasts 5:13 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Updates, advisories and surprises 4:31 p.m. Feb. 4, 2014 - MarketWatch
Gilead beats sales, earnings forecasts 4:27 p.m. Feb. 4, 2014 - Russ Britt
Gilead sales forecast beats $10.93B analyst view 4:18 p.m. Feb. 4, 2014 - Russ Britt
Gilead forecasts 2014 sales of $11.3B to $11.5B 4:17 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs of $3.12B beats $2.85B estimate 4:14 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 revs. are $3.12B vs 2012's $2.59B 4:13 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net of 55 cents beats views by 5 cents 4:12 p.m. Feb. 4, 2014 - Russ Britt
Gilead Q4 net is 55 cents vs. 2012's 50 cents 4:11 p.m. Feb. 4, 2014 - Russ Britt
Analyst upgrades Gilead, says biotech is 'too good not to own' 2:06 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Happy B-day, Facebook! Enjoy the gift of global market turmoil 7:10 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Yum Brands, Take-Two, CME are stocks to watch Tuesday 5:30 a.m. Feb. 4, 2014 - Sue Chang
More positive tests for hep C drug boost AbbVie and Enanta shares 10:52 a.m. Jan. 31, 2014 - blogs.marketwatch.com
Cash ain’t trash 1:55 p.m. Jan. 28, 2014 - The Trading Deck

Oncothyreon (ONTY) Jumps: Stock Moves 9.9% Higher - Tale of the Tape 9:46 a.m. Today - Zacks.com
Rigel Rises on Narrower Q4 Loss - Analyst Blog 9:40 a.m. Today - Zacks.com
Osiris Misses on Q4 Earnings - Analyst Blog 9:10 a.m. Today - Zacks.com
Bond Sales Spree Continues 8:12 p.m. March 5, 2014 - The Wall Street Journal Interactive Edition
The high cost of Gilead's Sovaldi giving Medicaid jaundice 12:33 p.m. March 5, 2014 - Seeking Alpha
Update on Alexion's Soliris - Analyst Blog 12:00 p.m. March 5, 2014 - Zacks.com
Dynavax Receives Milestone Payments from AstraZeneca - Analyst Blog 11:40 a.m. March 5, 2014 - Zacks.com
Pipeline Setback Overshadows XOMA's Q4 - Analyst Blog 10:52 a.m. March 5, 2014 - Zacks.com
Narrower-than-Expected Q4 Loss at GTx - Analyst Blog 9:50 a.m. March 5, 2014 - Zacks.com
Sunesis (SNSS) Jumps: Stock Moves 6.8% Higher - Tale of the Tape 9:25 a.m. March 5, 2014 - Zacks.com
Acorda Therapeutics (ACOR) Jumps: Stock Rises 7.5% - Tale of the Tape 9:18 a.m. March 5, 2014 - Zacks.com
Cramer's Mad Money - 5 Putin-Proof Sectors (3/4/14) 6:13 a.m. March 5, 2014 - Seeking Alpha
Bull of the Day: Quintiles (Q) - Bull of the Day 3:59 a.m. March 5, 2014 - Zacks.com
Jim Cramer's 'Mad Money' Recap: Stocks on Sale 8:08 p.m. March 4, 2014 - TheStreet.com
High-Grade Firms Dive Into Debt Market 5:48 p.m. March 4, 2014 - The Wall Street Journal Interactive Edition
AbbVie HCV Combination Therapy Data Looks Good - Analyst Blog 5:10 p.m. March 4, 2014 - Zacks.com
Isis Pharma Slips on Wider-Than-Expected Q4 Loss - Analyst Blog 3:06 p.m. March 4, 2014 - Zacks.com
Theravance to Split in Q2 - Analyst Blog 12:00 p.m. March 4, 2014 - Zacks.com
Celldex Posts Narrower-Than-Expected Loss in Q4 - Analyst Blog 11:30 a.m. March 4, 2014 - Zacks.com
Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog 11:00 a.m. March 4, 2014 - Zacks.com

Patient Support Programs, Financial Results, and Stock Price Movements - Analyst Notes on Gilead, Forest Laboratories, Thermo Fisher Scientific, HCA Holdings, and Nektar 8:25 a.m. Today - PR Newswire - PRF
Critical Alerts For Baidu.com, Gilead Sciences, Deere, Alexion Pharmaceuticals, and Ford Released By InvestorsObserver 9:31 a.m. March 5, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 6:15 p.m. March 4, 2014 - BusinessWire - BZX
Insider Trading Profile Alerts for Cisco, Gilead Sciences, Exxon Mobil, Facebook, Microsoft, and Bank of America 8:30 a.m. March 3, 2014 - PR Newswire - PRF
Gilead Sciences to Present at the 34th Cowen & Co. Healthcare Conference on Monday, March 3 5:00 p.m. Feb. 28, 2014 - BusinessWire - BZX
Aethlon Medical Expands Clinical Network Through DaVita Agreement 3:01 p.m. Feb. 26, 2014 - ACCESSWIRE
Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Insider Trading Update for Gilead Sciences, eBay, Walt Disney, Hewlett-Packard, Newmont Mining, and Apple 8:30 a.m. Feb. 24, 2014 - PR Newswire - PRF
CURx Pharmaceuticals Announces License Agreement with Gilead Sciences 8:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Galectin Therapeutics Leaps Ahead with SBH Sciences Partnership 11:02 a.m. Feb. 13, 2014 - ACCESSWIRE
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Gilead Sciences to Present at Two Upcoming Investor Conferences 5:00 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C 4:05 p.m. Feb. 10, 2014 - BusinessWire - BZX
Gilead Sciences Announces Fourth Quarter and Full Year 2013 Financial Results 4:05 p.m. Feb. 4, 2014 - BusinessWire - BZX
Critical Alerts For Procter and Gamble, Randgold Resources, Cerner, Gilead Sciences, and Walter Energy Released By InvestorsObserver 9:31 a.m. Feb. 4, 2014 - PR Newswire - PRF
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India 12:30 a.m. Jan. 31, 2014 - PR Newswire - PRF
Gilead Sciences to Release Fourth Quarter and Year End 2013 Financial Results on Tuesday, February 4, 2014 5:00 p.m. Jan. 28, 2014 - BusinessWire - BZX
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EAF Relief Fund Launches After Learjet Disaster

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Quarterhill's Q3 2026 Call Teases Insight into ITS Growth

The clock's ticking down to November 10, and eyes are peeled for Quarterhill's Q3 financial debrief. Why the fuss? Well, they’ve made quite a name for themselves in the Intelligent Transportation System (ITS) scene, tossing AI into the mix to boot. If you’re playing in this space—or just sneaking a peek to see where tech’s steering us next—you might want to dial...

Windward Expands Maritime Scope with Azimut.ai Deal

An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...

SlidesAI Launches Standalone Platform for Presentations

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...

BAIC FOTON Expands With New Trucks in Africa

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...

Markets Split on Election Day: Dow Dips, Nasdaq Soars

Election Day rolled in like a wild card, with markets doing their dance that makes seasoned traders either groan or grin. This time, Tuesday saw the Dow slipping while the Nasdaq climbed higher, reflecting a split personality kind of session. Ain't it funny how one day can hold such different tales depending on which index gets your focus? Indices' Dance: Dow Down, Nasdaq...

PASCO scientific Appoints David Lopez as New CEO

New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...

Xi's Financial Vision: China's Path to Global Power

China's Grand Financial Strategy Alright, strap in as President Xi Jinping is back on the scene painting a bold picture for China's financial future. The guy doesn't mess around when he says finance is a linchpin for the country's modernization. China's got the pedal to the metal, aiming to transform its national clout into a financial juggernaut. Key Pillars of Financial...

Yuhang's Innovative Tech: Journalists Get A Front Row Seat

A Sneak Peek into Yuhang's Technological Leap Imagine strolling through a place where technology and nature coexist in harmony. That's exactly what journalists from around the globe got to experience during their recent jaunt to Yuhang District in Hangzhou. We're talking about reps from South Korea, Turkey, the U.S., and even Cuba getting a firsthand look at Yuhang's...

Latitude Expands Food Allergy Care to Long Island

New Clinic Brings Specialized Care to Long Island Listen, when it comes to healthcare, especially something as life-altering as food allergies, you're not just looking for any run-of-the-mill clinic. You're looking for the right place with the right people who get it. And folks in Long Island are getting something worth celebrating—a new clinic from Latitude Food...